Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313580 · ClinicalTrials.gov registry record · NA
Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile
A NA study of Cardiometabolic Syndrome, sponsored by University of Alabama, Tuscaloo.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06313580: Recruiting NA study of Cardiometabolic Syndrome, sponsored by University of Alabama, Tuscaloo.
NCT06313580 is a NA study of Cardiometabolic Syndrome that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 30 participants, below the 145-participant average among 9 other Cardiometabolic Syndrome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06313580, a NA study of Cardiometabolic Syndrome, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Among food products receiving attention for prebiotic functionality, spices represent a flavorful vehicle for cultivating a healthy gut microbiota. As the required doses of spice-derived polyphenols to elicit prebiotic and systemic metabolic effects are not well-characterized, additional research is warranted. Thus, the investigators propose to use a food-first synbiotic (prebiotic + probiotic) approach to examine alterations in the gut microbiota pre- and post-intervention/placebo and their relationship with systemic cardiometabolic effects mediated by short chain fatty acids (SCFA) and gut-derived metabolites.
Conditions Studied
Interventions
- OTHER Yogurt with added Spices
- OTHER Yogurt without added Spices
Study Locations (1)
Alabama
- The University of Alabama - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-06 |
| Phase | NA |
What NCT06313580 shows while recruiting
NCT06313580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 145-participant average among 9 other Cardiometabolic Syndrome trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Cardiometabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Yogurt with added Spices is the first listed.
NCT06313580 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06313580 about?
NCT06313580 is a clinical study titled "Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile". Among food products receiving attention for prebiotic functionality, spices represent a flavorful vehicle for cultivating a healthy gut microbiota. As the required doses of spice-derived polyphenols to elicit prebiotic and systemic metabolic effects are not well-characterized, additional research is...
What is the current status of trial NCT06313580?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-01. Estimated completion is 2025-06.
What conditions does trial NCT06313580 study?
This clinical trial studies the following conditions: Cardiometabolic Syndrome.
What interventions are being tested in trial NCT06313580?
The interventions under investigation include: Yogurt with added Spices (OTHER), Yogurt without added Spices (OTHER).
Who is sponsoring clinical trial NCT06313580?
This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06313580 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiometabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06313580's enrollment target sits among peer trials
30 8th of 9 higher than 2 of 9 other Cardiometabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiometabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Impact of Yo-Yo Sleep on Cardiometabolic Health
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Telenutrition for Individuals With SCI
RECRUITING · NA
-
Spinal Cord Injury Model Systems (SCIMS) - Education Module
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI